January 28, 2023
Medthority
FDA appproves Keytruda for adjuvant treatment following surgical resection and chemotherapy for NSCLC.- Merck Inc.,
Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has approved... See more »
